Related references
Note: Only part of the references are listed.Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
Torsten O. Nielsen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Inter-Individual Variation in Response to Estrogen in Human Breast Explants
Karen A. Dunphy et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2020)
Discordance in 21-gene recurrence scores between paired breast cancer samples is inversely associated with patient age
Sarah M. Bernhardt et al.
BREAST CANCER RESEARCH (2020)
Menstrual cycling critically affects the Oncotype DX 21-gene signature: Implications for predictive biomarker assays in premenopausal women
Sarah M. Bernhardt et al.
CANCER RESEARCH (2020)
Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone
Ivana Sestak et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Menstrual cycle associated changes in hormone-related gene expression in oestrogen receptor positive breast cancer
Ben P. Haynes et al.
NPJ BREAST CANCER (2019)
PAM50 Risk of Recurrence Score Predicts 10-Year Distant Recurrence in a Comprehensive Danish Cohort of Postmenopausal Women Allocated to 5 Years of Endocrine Therapy for Hormone Receptor-Positive Early Breast Cancer
Anne-Vibeke Laenkholm et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Effect of chronic estradiol plus progesterone treatment on experimental arterial and venous thrombosis in mouse
Marie-Cecile Valera et al.
PLOS ONE (2017)
Breast Cancer Suppression by Progesterone Receptors Is Mediated by Their Modulation of Estrogen Receptors and RNA Polymerase III
Jessica Finlay-Schultz et al.
CANCER RESEARCH (2017)
Breast cancer in young women: an overview
Zoi Anastasiadi et al.
UPDATES IN SURGERY (2017)
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Lyndsay N. Harris et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
F. Cardoso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer
Hari Singhal et al.
SCIENCE ADVANCES (2016)
Hormonal Modulation of Breast Cancer Gene expression: Implications for Intrinsic Subtyping in Premenopausal Women
Sarah M. Bernhardt et al.
FRONTIERS IN ONCOLOGY (2016)
Progesterone Alleviates Endometriosis via Inhibition of Uterine Cell Proliferation, Inflammation and Angiogenesis in an Immunocompetent Mouse Model
Yanfen Li et al.
PLOS ONE (2016)
Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study
Dennis C. Sgroi et al.
BREAST CANCER RESEARCH (2016)
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
E. Senkus et al.
ANNALS OF ONCOLOGY (2015)
Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
A. S. Coates et al.
ANNALS OF ONCOLOGY (2015)
The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtype
Eleanor F. Need et al.
BMC CANCER (2015)
Progesterone receptor modulates ERα action in breast cancer
Hisham Mohammed et al.
NATURE (2015)
Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system
Antonis Koussounadis et al.
SCIENTIFIC REPORTS (2015)
Differences in expression of proliferation-associated genes and RANKL across the menstrual cycle in estrogen receptor-positive primary breast cancer
Ben P. Haynes et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer
Mitsuchika Hosoda et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Expression of key oestrogen-regulated genes differs substantially across the menstrual cycle in oestrogen receptor-positive primary breast cancer
Ben P. Haynes et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Progesterone Stimulates Proliferation and Promotes Cytoplasmic Localization of the Cell Cycle Inhibitor p27 in Steroid Receptor Positive Breast Cancers
Anastasia Kariagina et al.
HORMONES & CANCER (2013)
Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures
Peter Kabos et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Epithelial progesterone receptor exhibits pleiotropic roles in uterine development and function
Heather L. Franco et al.
FASEB JOURNAL (2012)
Insights into the regulation of protein abundance from proteomic and transcriptomic analyses
Christine Vogel et al.
NATURE REVIEWS GENETICS (2012)
Estrogen Receptor (ESR1) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor-Positive Breast Cancer
Chungyeul Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
Mitch Dowsett et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Global quantification of mammalian gene expression control
Bjoern Schwanhaeusser et al.
NATURE (2011)
A Mouse Model to Dissect Progesterone Signaling in the Female Reproductive Tract and Mammary Gland
Rodrigo Fernandez-Valdivia et al.
GENESIS (2010)
Elevated Breast Cancer Mortality in Women Younger than Age 40 Years Compared with Older Women Is Attributed to Poorer Survival in Early-Stage Disease
Jennifer L. Gnerlich et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2009)
Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery
Jessica Kao et al.
PLOS ONE (2009)
Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment
Hanna Fredholm et al.
PLOS ONE (2009)
Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer:: Predictive value of centrally reviewed expression of estrogen and progesterone receptors -: International Breast Cancer Study Group
Giuseppe Viale et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
A model of acquired autoresistance to a potent ErbB2 tyrosine kinase inhibitor and a therapeutic strategy to prevent its onset in breast cancer
Wenle Xia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: A southwest oncology group study
G Arpino et al.
CLINICAL CANCER RESEARCH (2004)
The FK506-binding immunophilin FKBP51 is transcriptionally regulated by progestin and attenuates progestin responsiveness
TR Hubler et al.
ENDOCRINOLOGY (2003)
Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells
JK Richer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
